loading

Ligand Pharmaceuticals Inc Azioni (LGND) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
5.06%
47.63
45.33 42.81 51.81 41.53
Operating Expenses
51.95%
39.18
81.55 52.45 48.67 60.63
Benefits Costs and Expenses
61.89%
36.40
95.51 82.01 58.15 106.92
Costs And Expenses
61.89%
36.40
95.51 82.01 58.15 106.92
Operating Income/Loss
123.32%
8.444
-36.22 -9.637 3.143 -19.10
Nonoperating Income/Loss
119.90%
2.779
-13.96 -29.56 -9.482 -46.29
Income/Loss From Equity Method Investments
-
- -1.245 -1.194 -8.03
Income/Loss From Continuing Operations Before Tax
122.37%
11.22
-50.18 -39.20 -6.339 -65.39
Income Tax Expense/Benefit
182.49%
6.376
-7.729 -8.112 0.833 -13.48
Income/Loss From Continuing Operations After Tax
111.42%
4.847
-42.45 -31.09 -7.172 -51.91
Net Income/Loss
111.42%
4.847
-42.45 -31.09 -7.172 -51.91
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.71%
19.33
19.19 0.229 18.42 18.03
Diluted Average Shares
3.83%
19.93
19.19 -0.284 18.42 18.03
Basic Earnings Per Share
111.31%
0.25
-2.21 -1.72 -0.39 -2.88
Diluted Earnings Per Share
110.86%
0.24
-2.21 -1.68 -0.39 -2.88
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):